Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers

NCT07306949 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Transthyretin-type Cardiac Amyloidosis

Interventions

DRUG: Acoramidis

Sponsor

Alexion Pharmaceuticals, Inc.